RxDoctor Payments Data

Rondell Graham

Clinical Pathology/Laboratory Medicine · Rochester, MNNPI 1174754279

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $65,572 of the $71,137 with a category attached, or 92.2%. 9 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 48.3% of the total. Among clinical pathology/laboratory medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,137in general payments, 2019–2025

Across 40 payments — averaging $1778.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$34K
  • Daiichi Sankyo Inc.$9K
  • Incyte Corporation$7K
  • GSK$6K
  • Astellas Pharma Global Development$6K
  • Biontech SE$5K
  • plus $4K from 3 others
$413,184in research payments, 2019–2025

Across 6 payments — averaging $68,864 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astellas Pharma Global Development$413K

What the payments were for

  • Consulting fees$65,57292%
  • Travel & lodging$5,1027%
  • Food & beverage$4641%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,137 in reported general payments places this provider in the 95th percentile of 30 clinical pathology/laboratory medicine providers in Minnesota.

See all clinical pathology/laboratory medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$55,640
Medicare patients
415
Services billed
1,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →